ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-pxxxviii.xml JNCCN CE Offerings2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-pxxxviii.pdf2026-04-18 JNCCN CE Offeringshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-pxxii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-pxxii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-pxxxiv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-pxxxiv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p395.xmlMelanoma, Version 2.20132026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p395.pdf2026-04-18Melanoma, Version 2.2013https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p414.xmlRadiation Therapy Modalities in Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p414.pdf2026-04-18Radiation Therapy Modalities in Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p389.xmlA Patient With Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer With Development of Leptomeningeal Carcinomatosis While on Targeted Treatment With Crizotinib2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p389.pdf2026-04-18A Patient With Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer With Development of Leptomeningeal Carcinomatosis While on Targeted Treatment With Crizotinibhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p373.xmlPart 2: Abstracts From the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p373.pdf2026-04-18Part 2: Abstracts From the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p368.xmlImplications of the FDA Draft Guidance on Biosimilars for Clinicians: What We Know and Don't Know2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p368.pdf2026-04-18Implications of the FDA Draft Guidance on Biosimilars for Clinicians: What We Know and Don't Knowhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p365.xmlCorrespondence2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p365.pdf2026-04-18Correspondencehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p366.xmlCorrespondence2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p366.pdf2026-04-18Correspondencehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p363.xmlNCCN Welcomes 2 New Member Institutions2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p363.pdf2026-04-18NCCN Welcomes 2 New Member Institutionshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p424.xmlA Review of the Symptomatic Management of Malignant Gliomas in Adults2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p424.pdf2026-04-18A Review of the Symptomatic Management of Malignant Gliomas in Adultshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p446.xmlBladder Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p446.pdf2026-04-18Bladder Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p502.xmlPhysician Burnout2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p502.pdf2026-04-18Physician Burnouthttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p492.xmlQuality Indicators in the Management of Bladder Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p492.pdf2026-04-18Quality Indicators in the Management of Bladder Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p431.xmlUsing NCCN Clinical Practice Guidelines in Oncology to Measure the Quality of Colorectal Cancer Care in the Veterans Health Administration2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p431.pdf2026-04-18Using NCCN Clinical Practice Guidelines in Oncology to Measure the Quality of Colorectal Cancer Care in the Veterans Health Administrationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p477.xmlPerioperative Intravesical Chemotherapy in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/4/article-p477.pdf2026-04-18Perioperative Intravesical Chemotherapy in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysishttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_2/article-pS-1.xmlData Needs in Oncology: “Making Sense of The Big Data Soup”2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/suppl_2/article-pS-1.pdf2026-04-18Data Needs in Oncology: “Making Sense of The Big Data Soup”